MannKind to Showcase at the Jefferies Global Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 11 2025
0mins
Source: Globenewswire
Conference Announcement: MannKind Corporation's CEO Michael Castagna and CFO Chris Prentiss will present updates at the Jefferies London Healthcare Conference on November 19, 2025, at 6:30 am ET/11:30 am GMT.
Webcast Availability: A live audio webcast of the presentation will be accessible on MannKind's website, with recorded versions available for 90 days post-conference.
Company Overview: MannKind Corporation is a biopharmaceutical company focused on innovative solutions for chronic diseases, particularly in cardiometabolic and orphan lung diseases.
Therapeutic Focus: The company develops treatments for serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
